Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Celecoxib induced toxiderma with positive patch-test].

S Verbeiren1, C Morant, H Charlanne

  • 1Service de Dermatologie, Centre Hospitalier Saint-Philibert, Université Catholique de Lille, 115, rue du Grand But, BP 249, 59462 Lille.

Annales De Dermatologie Et De Venereologie
|April 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel).

Annales de dermatologie et de venereologie·2025
Same author

Malignant syphilis: a rare presentation of a re-emerging disease.

Annales de dermatologie et de venereologie·2025
Same author

Ocular surface evaluation in atopic dermatitis patients on dupilumab: A prospective observational study.

Journal francais d'ophtalmologie·2025
Same author

Unilesional folliculotropic mycosis fungoides associated with follicular mucinosis in children: 2 cases and literature review.

Annales de dermatologie et de venereologie·2024
Same author

Cutaneous infection with cowpox virus in the setting of a natural disaster.

Annales de dermatologie et de venereologie·2024
Same author

Stevens-Johnson syndrome induced by lacosamide: A rare adverse reaction.

Annales de dermatologie et de venereologie·2023

A maculopapular rash developed in a patient taking celecoxib, a non-steroidal anti-inflammatory drug. Positive patch tests confirmed celecoxib as the cause, highlighting potential cutaneous reactions.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Celecoxib (Celebrex®) is a new-generation non-steroidal anti-inflammatory drug (NSAID).
  • NSAIDs are commonly prescribed for pain and inflammation.

Observation:

  • A 40-year-old male developed a maculopapular rash after nine days of celecoxib treatment.
  • The rash resolved within a week of discontinuing the medication.

Findings:

  • Patch testing with celecoxib yielded a positive result at 48 hours.
  • The clinical presentation and diagnostic tests strongly implicated celecoxib.

Implications:

  • This case underscores the potential for cutaneous adverse reactions to celecoxib.
  • Healthcare providers should consider NSAID-induced rashes in patients presenting with similar symptoms.

Related Experiment Videos